Analyst Ratings for Xenon Pharmaceuticals (XENE)
XENE Rating Summary
XENE Price Target Summary
- Highest: $90.00 (Guggenheim)
- Lowest: $55.00 (Cantor Fitzgerald)
- Average: $72.36
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$72.36 (+8.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$72.36 (+8.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
60.00 (N/A) |
42.23 (66.70) |
57.94% | Details |
| 9/3/2025 | Wells Fargo » Updated 3/10/2026 |
Benjamin Burnett | New Coverage | Overweight (N/A) |
68.00 (49.00) |
38.71 (66.70) |
72.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
